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Staphylococcal enterotoxin specific IgE in serum is linked to severe asthma and nasal polyposis 
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Introduction 
Staphylococcus aureus produces enterotoxins which have potent polyclonal immunostimulatory effects. IgE 
directed to these enterotoxins has been detected in serum of asthma, nasal polyp, allergic rhinitis and atopic 
dermatitis patients, but can also be present in serum of healthy subjects. Aim of the study was to assess the 
association of sensitization to enterotoxins with chronic rhinosinusitis, asthma and atopy presence and severity.  
Methods: The study was designed as a multicenter, non-matched case-control study, and recruited CRS subjects 
with nasal polyps (CRSwNP), without nasal polyps (CRSsNP), and controls undergoing septoplasty or 
conchotomy. Serum was analyzed for total IgE and for SAE-IgE (SEA, SEC and TSST-1). Sensitization was 
defined as SAE-IgE > 0,35 kU/L. Asthma severity was classified according to medication use based on NHLBI 
guidelines. 
Results: 794 serum samples were collected. Of these, 189 were controls, 378 has CRSsNP and 189 had 
CRSwNP. Asthma was present in 11.1% of controls, 19.2% of CRSsNP subjects and in 39.2% of CRSwNP 
subjects. Moderate to severe asthma was present in 7.4% of controls, 10.2% of CRSsNP and in 28.3 of CRSwNP 
subjects. SAE-IgE levels were positive in  15,7 % of controls, in 19,6% of CRSsNP and in 29,6% of CRSwNP. 
Non-asthmatics had in 19,4% SAE sensitization, compared to 19,1% of intermittent to mild asthmatics and 40,2 
% of moderate to severe asthmatics. Binary logistic regression revealed significant and independent associations 
of SAE-IgE presence with moderate-severe asthma and nasal polyposis. When taking in account the titer of 
SAE-IgE using multinomial logistic regression, moderate levels of IgE (0.35-1 kU/L) were associated with nasal 
polyposis and moderate-severe asthma, whereas high levels (>1 kU/L) were associated with moderate-severe 
asthma. After controlling for asthma and sinus disease, atopy was not associated with SAE-IgE. 
Conclusions: Serum presence of IgE to staphylococcal enterotoxins was strongly associated with moderate to 
severe asthma and nasal polyposis, independently of the presence of atopy. This underlines a potential role for 
staphylococcal superantigens in the pathogenesis of severe asthma, nasal polyposis and in their systemic 
interaction. 
